Medtronic, headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota, is a multinational medical technology company. Founded in 1949 by Earl Bakken and Palmer Hermundslie, Medtronic began as a medical equipment repair company. It introduced its first portable, battery-powered cardiac pacemaker in 1957, revolutionizing the treatment of heart diseases.

Today, Medtronic is the world's largest medical device company, operating in over 150 countries and employing more than 90,000 people globally. The company offers a wide range of medical technologies, including cardiac and vascular devices, surgical technologies, diabetes management products, and neurological therapies, aimed at improving patient outcomes and enhancing medical and surgical procedures. Medtronic's major product lines include pacemakers, defibrillators, heart valves, insulin pumps, spinal implants, surgical navigation systems, and neuromodulation devices.

The company has developed innovative technologies like the MiniMed insulin pump and the Micra transcatheter pacing system, further establishing its market presence. Medtronic has a robust global presence, with regional headquarters and manufacturing facilities in the Americas, Europe, Asia Pacific, and the Middle East. The company operates through a number of subsidiaries and has formed several notable partnerships and joint ventures to expand its capabilities and market reach.

Some noteworthy subsidiaries include Covidien, a leader in surgical solutions, and Mazor Robotics, a pioneer in surgical robotics. Medtronic holds a strong market position, generating an estimated $28 billion in global sales in 2021. It faces competition from companies like Johnson & Johnson, Abbott Laboratories, and Boston Scientific.

However, Medtronic's comprehensive portfolio, diverse customer base, and focus on innovation have contributed to its leading market position. In recent years, Medtronic has made significant advancements in areas like minimally invasive therapies, robotics, and remote patient monitoring. The company has also expanded its presence in emerging markets, aiming to address unmet medical needs and increase access to healthcare globally.

As of the latest updates, Medtronic continues to pursue its mission of transforming healthcare by advancing medical technologies and improving patient outcomes. The company remains committed to innovation, R&D investments, and strategic partnerships to maintain its position as a global leader in the medical technology industry